Skip to main content
ArticleOPEN ACCESS

Endocan is a reliable biomarker during continuous renal replacement therapy

Critical Care
DOI: 10.1186/s13054-019-2585-4
1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Hureau, M., Gaudet, A., De Freitas Caires, N., Parmentier, E., Poissy, J., Duburcq, T., … Mathieu, D. (2019, September 3). Endocan is a reliable biomarker during continuous renal replacement therapy. Critical Care. BioMed Central Ltd. https://doi.org/10.1186/s13054-019-2585-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free